Concerns regarding the health and well-being of populations of low-and middle-income countries (LMIC), particularly those of sub-Saharan Africa (SSA), have typically focused on problems that many in the US and other highincome countries (HICs) consider diseases of the past. For many countries in sub-Saharan Africa, infectious diseases like HIV, tuberculosis, and malaria along with the consequences of malnutrition and challenges in maternal and child health, while for HICs chronic non-communicable diseases of middle and older agescancer, coronary artery and cerebrovascular disease, diabetes, dementiapose major threats to the health of their populations. However, In SSA, the picture is slowly but surely evolving with the threat of non-communicable diseases, including cancers, looming large.This transformation is due to two parallel phenomena observed in that part of the world. The first is the impact of the scale-up of effective anti-retroviral therapy for HIV, resulting in a truly remarkable transformation of HIV from "a death sentence" to a chronic, manageable condition.as well as substantial progress in malaria control and in decreases in maternal and child mortality. Advances in management of HIV have resulted in a substantial increase in life expectancy among people living with HIV in SSA, with such individuals now surviving into middle and older ages. The aging of this population is a critical factor in their increased susceptibility to non-communicable diseases. 2,3 At the same time, many LMICs, including those in SSA, are experiencing economic growth. Although profound disparities in wealth remain, this economic growth, which is welcomed, has resulted in fundamental changes in lifestyles, with increase in caloric intake, tobacco smoking and sedentary status. These realities put sub-Saharan African populations at increased risk for diseases that are associated with the Western lifestyle, notably certain cancers, coronary heart disease, stroke, and diabetes. Tobacco use has been on the rise, partially due to tobacco companies targeting LMICs due to loss of sales in HICs, as have obesity